跳至主要内容
临床试验/CTRI/2019/02/017634
CTRI/2019/02/017634招募中2 期

Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinsonâ??s Disease- A Pilot study

Sun Pharmaceutical Industries Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • PD diagnosed according to UKPD Brain Bank criteria
  • Patients who meet criteria for tremor dominant PD, as described in methodology below.
  • Men and women of age 18 to 85.
  • PD patients on stable dose of antiparkinsonian drug for last 3 months.

排除标准

  • Patients of Atypical PD (diagnosed as per clinical criteria)
  • Patients of PD on other non- antiparkinsonian drugs which might affect tremor, such as beta-agonists, beta- blockers, anti-epileptics such as phenytoin, valproate, carbamazepine.
  • History of psychiatric illness
  • Severe cognitive impairment(MMSE <=21)
  • Hepatic or renal disease
  • Pregnancy and breast feeding
  • Known allergy to Zonisamide

研究者

相似试验